These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 30277442)

  • 21. Cancer Imaging Phenomics via CaPTk: Multi-Institutional Prediction of Progression-Free Survival and Pattern of Recurrence in Glioblastoma.
    Fathi Kazerooni A; Akbari H; Shukla G; Badve C; Rudie JD; Sako C; Rathore S; Bakas S; Pati S; Singh A; Bergman M; Ha SM; Kontos D; Nasrallah M; Bagley SJ; Lustig RA; O'Rourke DM; Sloan AE; Barnholtz-Sloan JS; Mohan S; Bilello M; Davatzikos C
    JCO Clin Cancer Inform; 2020 Mar; 4():234-244. PubMed ID: 32191542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IDH1 mutation prediction using MR-based radiomics in glioblastoma: comparison between manual and fully automated deep learning-based approach of tumor segmentation.
    Choi Y; Nam Y; Lee YS; Kim J; Ahn KJ; Jang J; Shin NY; Kim BS; Jeon SS
    Eur J Radiol; 2020 Jul; 128():109031. PubMed ID: 32417712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative volumetric assessment of baseline enhancing tumor volume as an imaging biomarker predicts overall survival in patients with glioblastoma.
    Auer TA; Della Seta M; Collettini F; Chapiro J; Zschaeck S; Ghadjar P; Badakhshi H; Florange J; Hamm B; Budach V; Kaul D
    Acta Radiol; 2021 Sep; 62(9):1200-1207. PubMed ID: 32938221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiogenomic analysis of PTEN mutation in glioblastoma using preoperative multi-parametric magnetic resonance imaging.
    Li Y; Liang Y; Sun Z; Xu K; Fan X; Li S; Zhang Z; Jiang T; Liu X; Wang Y
    Neuroradiology; 2019 Nov; 61(11):1229-1237. PubMed ID: 31218383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Large-scale Radiomic Profiling of Recurrent Glioblastoma Identifies an Imaging Predictor for Stratifying Anti-Angiogenic Treatment Response.
    Kickingereder P; Götz M; Muschelli J; Wick A; Neuberger U; Shinohara RT; Sill M; Nowosielski M; Schlemmer HP; Radbruch A; Wick W; Bendszus M; Maier-Hein KH; Bonekamp D
    Clin Cancer Res; 2016 Dec; 22(23):5765-5771. PubMed ID: 27803067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A quantitative study of shape descriptors from glioblastoma multiforme phenotypes for predicting survival outcome.
    Chaddad A; Desrosiers C; Hassan L; Tanougast C
    Br J Radiol; 2016 Dec; 89(1068):20160575. PubMed ID: 27781499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiregional radiomics profiling from multiparametric MRI: Identifying an imaging predictor of IDH1 mutation status in glioblastoma.
    Li ZC; Bai H; Sun Q; Zhao Y; Lv Y; Zhou J; Liang C; Chen Y; Liang D; Zheng H
    Cancer Med; 2018 Dec; 7(12):5999-6009. PubMed ID: 30426720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of Prognosis in Glioblastoma Using Radiomics Features of Dynamic Contrast-Enhanced MRI.
    Pak E; Choi KS; Choi SH; Park CK; Kim TM; Park SH; Lee JH; Lee ST; Hwang I; Yoo RE; Kang KM; Yun TJ; Kim JH; Sohn CH
    Korean J Radiol; 2021 Sep; 22(9):1514-1524. PubMed ID: 34269536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiparametric MRI-based fusion radiomics for predicting telomerase reverse transcriptase (TERT) promoter mutations and progression-free survival in glioblastoma: a multicentre study.
    Zhang H; Zhang H; Zhang Y; Zhou B; Wu L; Yang W; Lei Y; Huang B
    Neuroradiology; 2024 Jan; 66(1):81-92. PubMed ID: 37978079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MRI Atlas of IDH Wild-Type Supratentorial Glioblastoma: Probabilistic Maps of Phenotype, Management, and Outcomes.
    Roux A; Roca P; Edjlali M; Sato K; Zanello M; Dezamis E; Gori P; Lion S; Fleury A; Dhermain F; Meder JF; Chrétien F; Lechapt E; Varlet P; Oppenheim C; Pallud J
    Radiology; 2019 Dec; 293(3):633-643. PubMed ID: 31592732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Nomogram of MRI-based Radiomics with Complementary Visual Features by Machine Learning Improves Stratification of Glioblastoma Patients: A Multicenter Study.
    Xu Y; He X; Li Y; Pang P; Shu Z; Gong X
    J Magn Reson Imaging; 2021 Aug; 54(2):571-583. PubMed ID: 33559302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multi-Parametric Deep Learning Model for Prediction of Overall Survival after Postoperative Concurrent Chemoradiotherapy in Glioblastoma Patients.
    Yoon HG; Cheon W; Jeong SW; Kim HS; Kim K; Nam H; Han Y; Lim DH
    Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32823939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elderly patients with newly diagnosed glioblastoma: can preoperative imaging descriptors improve the predictive power of a survival model?
    Park M; Lee SK; Chang JH; Kang SG; Kim EH; Kim SH; Song MK; Ma BG; Ahn SS
    J Neurooncol; 2017 Sep; 134(2):423-431. PubMed ID: 28674975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combining multimodal imaging and treatment features improves machine learning-based prognostic assessment in patients with glioblastoma multiforme.
    Peeken JC; Goldberg T; Pyka T; Bernhofer M; Wiestler B; Kessel KA; Tafti PD; Nüsslin F; Braun AE; Zimmer C; Rost B; Combs SE
    Cancer Med; 2019 Jan; 8(1):128-136. PubMed ID: 30561851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical measures, radiomics, and genomics offer synergistic value in AI-based prediction of overall survival in patients with glioblastoma.
    Fathi Kazerooni A; Saxena S; Toorens E; Tu D; Bashyam V; Akbari H; Mamourian E; Sako C; Koumenis C; Verginadis I; Verma R; Shinohara RT; Desai AS; Lustig RA; Brem S; Mohan S; Bagley SJ; Ganguly T; O'Rourke DM; Bakas S; Nasrallah MP; Davatzikos C
    Sci Rep; 2022 May; 12(1):8784. PubMed ID: 35610333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genotype prediction of ATRX mutation in lower-grade gliomas using an MRI radiomics signature.
    Li Y; Liu X; Qian Z; Sun Z; Xu K; Wang K; Fan X; Zhang Z; Li S; Wang Y; Jiang T
    Eur Radiol; 2018 Jul; 28(7):2960-2968. PubMed ID: 29404769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regression based overall survival prediction of glioblastoma multiforme patients using a single discovery cohort of multi-institutional multi-channel MR images.
    Sanghani P; Ang BT; King NKK; Ren H
    Med Biol Eng Comput; 2019 Aug; 57(8):1683-1691. PubMed ID: 31104273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiogenomic-Based Survival Risk Stratification of Tumor Habitat on Gd-T1w MRI Is Associated with Biological Processes in Glioblastoma.
    Beig N; Bera K; Prasanna P; Antunes J; Correa R; Singh S; Saeed Bamashmos A; Ismail M; Braman N; Verma R; Hill VB; Statsevych V; Ahluwalia MS; Varadan V; Madabhushi A; Tiwari P
    Clin Cancer Res; 2020 Apr; 26(8):1866-1876. PubMed ID: 32079590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MRI Radiomic Features: Association with Disease-Free Survival in Patients with Triple-Negative Breast Cancer.
    Kim S; Kim MJ; Kim EK; Yoon JH; Park VY
    Sci Rep; 2020 Feb; 10(1):3750. PubMed ID: 32111957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting survival in patients with glioblastoma using MRI radiomic features extracted from radiation planning volumes.
    Geraghty BJ; Dasgupta A; Sandhu M; Malik N; Maralani PJ; Detsky J; Tseng CL; Soliman H; Myrehaug S; Husain Z; Perry J; Lau A; Sahgal A; Czarnota GJ
    J Neurooncol; 2022 Feb; 156(3):579-588. PubMed ID: 34981301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.